Faraj K Alenezi1,2, Khalid Alnababtah3, Mohammed M Alqahtani4, Lafi Olayan5, Mohammed Alharbi5,6. 1. Anesthesia Technology Program, College of Applied Medical Sciences, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia. farajalenezi@gmail.com. 2. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. farajalenezi@gmail.com. 3. School of Nursing and Midwifery, Faculty of Health, Education and Life Sciences, BCU, Birmingham, UK. 4. Respiratory Therapy Program, College of Applied Medical Sciences, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia. 5. Anesthesia Technology Program, College of Applied Medical Sciences, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia. 6. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abstract
BACKGROUND: Inadequate neuromuscular recovery might impair pulmonary function among adult patients who undergo general anaesthesia and might thus contribute to critical respiratory events in the post-anaesthesia care unit (PACU). The pilot study aims to understand the baseline incidence of residual neuromuscular blockade (RNMB) and postoperative critical respiratory events (CREs), which are described in a modified Murphy's criteria in the PACU. METHOD: This is a prospective cohort study from January to March 2017 from a tertiary hospital in Saudi Arabia with thirty adult patients over 18 years old scheduled for elective surgery under general anaesthesia with neuromuscular blocking drugs (NMBDs) who were enrolled in the study. The Mann-Whitney U tests, chi-square tests and independent-samples T tests were used. The train-of-four (TOF) ratios were measured upon arrival in the PACU by using acceleromyography with TOF-Scan. Subjects' demographics, perioperative data and the occurrence of postoperative CREs in the PACU were recorded. RESULTS: Twenty-six (86.7%) patients out of thirty in the study have received rocuronium as NMBDs whilst neostigmine as a reversal drug with only 23 (76.7%). The incidence of RNMB (TOF ratio < 0.9) was in 16 patients (53.3%). The incidence of RNMB was significantly higher in female patients (p = 0.033), in patients who had not undergone quantitative neuromuscular monitoring before extubation (p = 0.046) and in patients with a shorter duration of surgery (p = 0.001). Postoperative CREs occurred in twenty patients (66.7%), and there were significantly more of these CREs among patients with RNMB (p = 0.001). In addition, a statistically significant difference was observed in the occurrence of CREs according to body mass index (p = 0.047). CONCLUSION: This research showed that RNMB is a significant contributing factor to the development of critical respiratory events during PACU stay. Therefore, routine quantitative neuromuscular monitoring is recommended to reduce the incidence of RNMB.
BACKGROUND: Inadequate neuromuscular recovery might impair pulmonary function among adult patients who undergo general anaesthesia and might thus contribute to critical respiratory events in the post-anaesthesia care unit (PACU). The pilot study aims to understand the baseline incidence of residual neuromuscular blockade (RNMB) and postoperative critical respiratory events (CREs), which are described in a modified Murphy's criteria in the PACU. METHOD: This is a prospective cohort study from January to March 2017 from a tertiary hospital in Saudi Arabia with thirty adult patients over 18 years old scheduled for elective surgery under general anaesthesia with neuromuscular blocking drugs (NMBDs) who were enrolled in the study. The Mann-Whitney U tests, chi-square tests and independent-samples T tests were used. The train-of-four (TOF) ratios were measured upon arrival in the PACU by using acceleromyography with TOF-Scan. Subjects' demographics, perioperative data and the occurrence of postoperative CREs in the PACU were recorded. RESULTS: Twenty-six (86.7%) patients out of thirty in the study have received rocuronium as NMBDs whilst neostigmine as a reversal drug with only 23 (76.7%). The incidence of RNMB (TOF ratio < 0.9) was in 16 patients (53.3%). The incidence of RNMB was significantly higher in female patients (p = 0.033), in patients who had not undergone quantitative neuromuscular monitoring before extubation (p = 0.046) and in patients with a shorter duration of surgery (p = 0.001). Postoperative CREs occurred in twenty patients (66.7%), and there were significantly more of these CREs among patients with RNMB (p = 0.001). In addition, a statistically significant difference was observed in the occurrence of CREs according to body mass index (p = 0.047). CONCLUSION: This research showed that RNMB is a significant contributing factor to the development of critical respiratory events during PACU stay. Therefore, routine quantitative neuromuscular monitoring is recommended to reduce the incidence of RNMB.
Authors: Louis-Philippe Fortier; Dolores McKeen; Kim Turner; Étienne de Médicis; Brian Warriner; Philip M Jones; Alan Chaput; Jean-François Pouliot; André Galarneau Journal: Anesth Analg Date: 2015-08 Impact factor: 5.108
Authors: Anna I Hårdemark Cedborg; Eva Sundman; Katarina Bodén; Hanne Witt Hedström; Richard Kuylenstierna; Olle Ekberg; Lars I Eriksson Journal: Anesthesiology Date: 2014-02 Impact factor: 7.892
Authors: Eva Kirmeier; Lars I Eriksson; Heidrun Lewald; Malin Jonsson Fagerlund; Andreas Hoeft; Markus Hollmann; Claude Meistelman; Jennifer M Hunter; Kurt Ulm; Manfred Blobner Journal: Lancet Respir Med Date: 2018-09-14 Impact factor: 30.700